We predicted that the “STMN1-p38MAPK/STAT1-ZEB1-EMT” axis would promote NSCLC metastasis, and our research team is also preparing to further validate the “STAT1-ZEB1-EMT” section. This evidence concerns the gene ZEB1 and non-small cell lung carcinoma.